1. Konno, M., Matsui, H., Koseki, J., Asai, A., Kano, Y., Kawamoto, K., Nishida, N., Sakai, D., Kudo, T., Satoh, T., Doki, Y., Mori, M., Ishii, H. Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells. Sci. Rep., 2018, 8(1):899.
2. Koseki, J., Konno, M., Asai, A., Colvin, S. H., Kawamoto, K., Nishida, N., Sakai, D., Kudo, T., Satoh, T., Doki, Y., Mori, M., Ishii H. Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis. Sci. Rep., 2018, 8(1):303.
3. Nishizawa, Y., Konno, M., Asai, A., Koseki, J., Kawamoto, K., Miyoshi, N., Takahashi, H., Nishida, N., Haraguchi, N., Sakai, D., Kudo, T., Hata, T., Matsuda, C., Mizushima, T., Satoh, T., Doki, Y., Mori, M., Ishii, H. Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer. Int. J. Oncol., 2018, 52(2):453-460.
4. Nishizawa, Y., Konno, M., Asai, A., Koseki, J., Kawamoto, K., Miyoshi, N., Takahashi, H., Nishida, N., Haraguchi, N., Sakai, D., Kudo, T., Hata, T., Matsuda, C., Mizushima, T., Satoh, T., Doki, Y., Mori, M., Ishii H. Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer. Oncotarget, 2017, 9(7):7476-7486.
5. Asukai, K., Kawamoto, K., Eguchi, H., Konno, M., Asai, A., Iwagami, Y., Yamada, D., Asaoka, T., Noda, T., Wada, H., Gotoh, K., Nishida, N., Satoh, T., Doki, Y., Mori, M., Ishii, H. Micro-RNA-130a-3p regulates gemcitabine resistance via PPARG in cholangiocarcinoma. Ann. Surg. Oncol., 2017, 24(8):2344-2352.
6. Konno, M., Asai, A., Kawamoto, K., Nishida, N., Satoh, T., Doki, Y., Mori, M., Ishii, H. The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer. Int. J. Oncol., 2017, 50(4):1057-1063.